featured
Bevacizumab Plus Irinotecan vs Temozolomide in Newly Diagnosed MGMT Nonmethylated Glioblastoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS Trial
J. Clin. Oncol 2016 Mar 14;[EPub Ahead of Print], U Herrlinger, N Schäfer, JP Steinbach, A Weyerbrock, P Hau, R Goldbrunner, F Friedrich, V Rohde, F Ringel, U Schlegel, M Sabel, MW Ronellenfitsch, M Uhl, J Maciaczyk, S Grau, O Schnell, M Hänel, D Krex, P Vajkoczy, R Gerlach, RD Kortmann, M Mehdorn, J Tüttenberg, R Mayer-Steinacker, R Fietkau, S Brehmer, F Mack, M Stuplich, S Kebir, R Kohnen, E Dunkl, B Leutgeb, M Proescholdt, T Pietsch, H Urbach, C Belka, W Stummer, M GlasFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.